Mersana Therpts (NASDAQ:MRSN) reported earnings of ($6.33) per share missing Walls Streets expectations.

Mersana Therpts (NASDAQ:MRSN) reported Q2 2017 earnings this N/A, coming in at ($6.33) per share, missing Wall Street’s estimates of ($0.56) per Share. Revenue for the quarter came in at $3.73 million beating analyst estimates of $3.33 million

Analyst Coverage For Mersana Therpts (NASDAQ:MRSN)
These are 4 Buy Ratings .
The current consensus rating for Mersana Therpts (NASDAQ:MRSN) is Buy (Score: 3.00) with a consensus target price of $23.67 , a potential (53.48% upside)

Recent Insider Trading for Mersana Therpts (NASDAQ:MRSN)

  • On 7/3/2017 M James Barrett, Major Shareholder, bought 1,000,000 with an average share price of $15.00 per share and the total transaction amounting to $15,000,000.00.

    Recent Trading for Mersana Therpts (NASDAQ:MRSN)
    Shares of Mersana Therpts closed the previous trading session at 15.42 up +0.27 1.78% with 15,235 shares trading hands.

    An ad to help with our costs